We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novo Patent Fight Over Prandin To Stay In Minn.

Law360 (December 1, 2010, 2:48 PM EST) -- The federal judge overseeing Novo Nordisk Inc.'s patent infringement suit against Paddock Laboratories Inc. over diabetes drug Prandin has determined that the U.S. District Court for the District of Minnesota has priority to hear the parties' dispute over whether Novo has unlawfully monopolized the market for the drug.

Judge Donovan W. Frank of the U.S. District Court for the District of Minnesota on Tuesday denied Paddock's motion to dismiss the plaintiff's bid for a declaration that it did not engage in conduct that violates Section 2...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.